J J: Cancer Risk in Arthritis Drug  NEW YORK (Reuters) - Johnson   Johnson will send a letter  to doctors next Monday warning them that patients taking its  rheumatoid arthritis drug Remicade may have a higher risk of  lymphoma, a blood cancer, than those not taking the drug, the  company said on Friday.